Microviable Therapeutics, which develops oral drugs based on microbiota-derived products, hopes to soon open a financing round of more than five million euros to advance its research toward the clinical phase, according to Claudio Hidalgo, [...]
Microviable Therapeutics is celebrating World Microbiome Day 2023! We share how important microbes are for the health of humans, animals, plants, oceans and the entire planet. Through increased awareness and education we can create a [...]
We are looking for a full-time, highly motivated lab technician to work on our team on-site (Oviedo, Asturias, Spain). The ideal candidate will have experience in microbiology, biochemistry, immunology, microbiota and probiotics, and will join [...]
Our new research article: “GutAlive® enables DNA-based microbiome analysis without disrupting the original composition and diversity” A precise faecal microbiome analysis requires normalized methods for microbiome sampling, transport and manipulation in order to obtain [...]
We are looking for a full-time, highly motivated individual to work as a bioinformatician in our team to develop prediction models using artificial intelligence for novel biotherapeutics development. More information If you are interested [...]
From Microviable in the International Day of Women and Girls in Science, we want to speakup for all the female working in STEM (Science, Technology, Engineering and Mathematics), not only for their great work but [...]
Microviable Therapeutics is looking for a full-time, highly motivated individual to work as a Quality Assurance CMO specialist with cGMP experience for novel biotherapeutic products. More information If you are interested in working with [...]
The European Medicines Agency (EMA) granted the qualification of “Small and Medium-Sized Enterprises” (SME) to Microviable Therapeutics. The European Medicines Agency (EMA) provides incentives and support for micro, small and medium-sized enterprises (SMEs) that are [...]
Checkout our new GutAlive® !! The unique user-friendly, high-capacity device for stool collection sampling and transport in anaerobic conditions that ensures sample stability, microbiota viability and preserves DNA integrity. GutAlive® preserves the [...]
Gijón, 21st July 2022, Microviable Therapeutics SL, a biotechnology company in preclinical stage developing novel microbiome-derived biotherapeutic products, announced a research agreement with the University Medical Center of Utrecht (The Netherlands) and Artizan Biosciences [...]